Originally from Stafford Martin has over 30 years of experience in pharmaceutical marketing and medical communications. After starting his career in the UK, Martin moved to Switzerland with Novartis in the Organ Transplantation global marketing team. He then moved to the US joining Wyeth, later returning to Europe as commercial director for Transplantation and Haemophilia. In 2003 Martin returned to the US as head of Global Strategy for their flagship product in rheumatology overseeing its growth to a multibillion-dollar blockbuster.
Martin returned to the UK as Partner in London medical communications agency Synergy. He then established ELM group in 2014 returning home to Stafford permanently. ELM group has a core in medical communications working in areas such as rheumatology, haemophilia, rare diseases and more recently have done work on COVID therapies. The group enjoy unique collaborations with Universities of Glasgow and Leeds and has a partnership with the BMJ Group. Its People division has worked with Premiership rugby and Premier League football clubs as well as major companies developing and delivering training and volunteer programmes. His overall ambition is developing jobs in the life sciences sector for local graduates.
Outside of work Martin’s main interest is in Rugby, a sport that he supports in various capacities. He served on the legacy team for the 2015 Rugby World Cup and as Chairman of Stafford Rugby Club, where he negotiated the deal for the new £4 million facility at the heart of Stafford. He currently supports the Newcastle Falcons academy programme and is a referee assessor.